Author:
Pawara Rahul,Ahmad Iqrar,Nayak Deepika,Wagh Shivani,Wadkar Avinash,Ansari Azim,Belamkar Sateesh,Surana Sanjay,Nath Kundu Chanakya,Patil Chandragauda,Patel Harun
Funder
Ministry of Health and Family Welfare
Indian Council of Medical Research
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference72 articles.
1. Epidermal growth factor receptor mutations in lung cancer;Sharma;Nat. Rev. Cancer,2007
2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin. Proc.,2008
3. In-Silico Evidences for Binding of Glucokinase Activators to EGFR C797S to Overcome EGFR Resistance Obstacle with Mutant-Selective Allosteric Inhibition;Patel;Comput. Biol. Chem.,2018
4. p38α MAP kinase inhibitors to overcome EGFR tertiary C797S point mutation associated with osimertinib in non-small cell lung cancer (NSCLC): emergence of fourth-generation EGFR inhibitor;Ahmad;J. Biomol. Struct. Dyn.,2020
5. Role of receptor tyrosine kinases in lung cancer;Maulik;Methods Mol. Med.,2003
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献